Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.